Founded in 1952 by visionary physicians determined to find better treatments for their patients, The Lundquist Institute continues to be defined by its unique “bedside to bench to bedside” approach, translating clinical challenges into scientific inquiry, and scientific discoveries back into patient care.
Today, over 150 principal investigators and 400 research staff are driving forward more than 600 active studies and 100+ clinical trials, delivering solutions that are transforming lives. Affiliated with the David Geffen School of Medicine at UCLA and partnered with Harbor-UCLA Medical Center, The Lundquist Institute leads advancements in areas ranging from cancer biology and infectious diseases, and respiratory medicine to translational genomics.
Our Research Priorities
Cancer Biology and Immunotherapeutics
Translating cancer research into innovative, effective, value- and evidence-based treatments to improve patient survival and quality of life.
Health Services and Outcomes Research
Advancing scientific knowledge through multi-disciplinary collaboration to optimize health services and address disparities in care.
Infection and Immunity
Elevating the understanding, prevention, and treatment of infectious diseases by strengthening immune health and combating global health challenges.
Metabolic Diseases and Endocrinology
Expanding the understanding and treatment of metabolic disorders while promoting collaboration in areas such as diabetes, cardiology, reproductive health, thyroid care, and pediatric endocrinology.
Neurotherapeutics
Conducting innovative research and advancing therapies and treatments for brain health, neurodegenerative diseases, and cognitive function improvement.
Respiratory Medicine and Exercise Physiology
Enhancing the understanding and treatment of respiratory conditions by focusing on research in lung health, exercise physiology, and interventions for pulmonary diseases.
Translational Genomics
Bridging genetic research and clinical application by translating genomic discoveries into therapies for personalized medicine and the treatment of genetic disorders.
Women’s and Children’s Health
Promoting health advancements for women and children through research to improve maternal, pediatric, and adolescent health outcomes.
